title: [Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
authors.forename: A
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: P
authors.initials: P
authors.lastname: Pellegrino
authors.forename: C
authors.initials: C
authors.lastname: Poggi
authors.forename: N
authors.initials: N
authors.lastname: Profizi
authors.forename: R
authors.initials: R
authors.lastname: Quilichini
authors.forename: I
authors.initials: I
authors.lastname: Chouette
authors.forename: M S
authors.initials: MS
authors.lastname: Navarreté
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D004352:Drug Resistance, Microbial; D006801:Humans; D009285:Naphthoquinones / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy*
chemical_list: D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D053626:Atovaquone
vernacular_title: Efficacité de l'atovaquone dans les toxoplasmoses résistantes du SIDA.